~~<i id='93E95586B1'><strike id='93E95586B1'><tt id='93E95586B1'><pre id='93E95586B1'></pre></tt></strike></i>~~

Home» knowledge» entertainment

entertainment

author：comprehensive 2025-09-30 18:21:58 Page View：6

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Princess Kate attends Wimbledon with Roger Federer: See the photos
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

leisure time

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Medical schools are missing the mark on artificial intelligence

GUILLAUMESOUVANT/AFPviaGettyImagesReadyornot,healthcareisundergoingamassivetransformationdrivenbyart

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

2:59PresidentJoeBidenspeaksabouthisplansforcontinuedstudentdebtreliefafteraU.S.SupremeCourtdecisionb